semaglutide adverse events Summary of clinical trials that investigated weight loss using GLP-1 RAs linked to broad

EMA lleva meses investigando Al conocer las conclusiones de dos estudios observacionales sobre la influencia de la semaglutida en el incremento del riesgo de la neuropata ptica isqumica anterior no artertica (NAION, por sus siglas en ingls), una grave enfermedad ocular y pese a que otros estudios no hallaban una asociacin entre la semaglutida y un aumento de casos de NAION, la Agencia Europea del Medicamento decidi iniciar una nueva evaluacin

Pharmacists who supply compounded weight-loss and diabetes drugs already are discussing the situation with customers

Potential Kidney Benefits: Some evidence suggests GLP-1s may have protective effects on kidney function in diabetes patients

Prediabetes affects roughly 38% of the population, and most do not know they have it

This makes it harder for companies to use completely new ingredients

If you dont have steady fridge access, ask your pharmacist